CS logo
small CS logo
HAGA Ziekenhuis

Den Haag, Netherlands
Hospital in the Hague
Els Borst-Eilersplein 275, 2545 AA Den Haag

About HAGA Ziekenhuis


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Stichting Hemato-Oncologie voor Volwassenen Nederland
11
The Netherlands Cancer Institute
11
Vertex Pharmaceuticals Incorporated
11
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
10
European Organisation for Research and Treatment of Cancer - EORTC
8
Janssen Research & Development, LLC
7
Leiden University Medical Center
6
Maastricht University Medical Center
6
Celgene
5
Erasmus Medical Center
5
Pfizer
5
Total Rows: 85

Clinical Trials at HAGA Ziekenhuis


During the past decade, HAGA Ziekenhuis conducted 122 clinical trials. In the 10-year time frame, 122 clinical trials started and 41 clinical trials were completed, i.e. on average, 33.6% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 26 clinical trials were completed. i.e. 76.5% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1212161629291515161616166610102222223344441111557733Started TrialsCompleted Trails201520162017201820192020202120222023010203040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease
1989-09-01
Active, not recruiting
615
Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
1995-02-01
Unknown status
25
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia
1995-10-01
Unknown status
750
Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
1996-05-01
Completed
342
Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer
1996-06-01
2010-10-01
Completed
1,400
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
1996-12-01
Unknown status
80
Combination Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer
1998-08-01
Completed
450
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1998-10-01
Active, not recruiting
1,649

Rows per page:

1–100 of 202

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "HAGA Ziekenhuis" #1 sponsor was "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 11 trials, followed by "The Netherlands Cancer Institute" with 11 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 11 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 10 trials sponsored and "European Organisation for Research and Treatment of Cancer - EORTC" with 10 trials sponsored. Other sponsors include 146 different institutions and companies that sponsored additional 85 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "HAGA Ziekenhuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 12 trials as a collaborator, "Dutch Cancer Society" with 9 trials as a collaborator, "Borstkanker Onderzoek Groep" with 7 trials as a collaborator, "Erasmus Medical Center" with 6 trials as a collaborator and "Leiden University Medical Center" with 6 trials as a collaborator. Other collaborators include 243 different institutions and companies that were collaborators in the rest 193 trials.
Created with Highcharts 11.1.0Top Leading SponsorsStichting Hemato-Oncologie voorVolwassenenNederland: 11Stichting Hemato-Oncologie voorVolwassenenNederland: 11The Netherlands CancerInstitute: 11The Netherlands CancerInstitute: 11Vertex PharmaceuticalsIncorporated: 11Vertex PharmaceuticalsIncorporated: 11Academisch MedischCentrum - Universiteitvan Amsterdam (AMC-UvA): 10Academisch MedischCentrum - Universiteitvan Amsterdam (AMC-UvA): 10European Organisationfor Research andTreatment of Cancer -EORTC: 8European Organisationfor Research andTreatment of Cancer -EORTC: 8Janssen Research &Development, LLC: 7Janssen Research &Development, LLC: 7Leiden UniversityMedical Center: 6Leiden UniversityMedical Center: 6Maastricht UniversityMedical Center: 6Maastricht UniversityMedical Center: 6Celgene: 5Celgene: 5Erasmus Medical Center: 5Erasmus Medical Center: 5

Created with Highcharts 11.1.0Top CollaboratorsZonMw: TheNetherlandsOrganisation for HealthResearch andDevelopment: 12ZonMw: TheNetherlandsOrganisation for HealthResearch andDevelopment: 12Dutch Cancer Society: 9Dutch Cancer Society: 9Borstkanker OnderzoekGroep: 7Borstkanker OnderzoekGroep: 7Erasmus Medical Center: 6Erasmus Medical Center: 6Leiden UniversityMedical Center: 6Leiden UniversityMedical Center: 6Academisch MedischCentrum - Universiteitvan Amsterdam (AMC-UvA): 5Academisch MedischCentrum - Universiteitvan Amsterdam (AMC-UvA): 5Haga Hospital: 5Haga Hospital: 5Novartis: 4Novartis: 4Radboud UniversityMedical Center: 4Radboud UniversityMedical Center: 4Roche Pharma AG: 4Roche Pharma AG: 4

Clinical Trials Conditions at HAGA Ziekenhuis


According to Clinical.Site data, the most researched conditions in "HAGA Ziekenhuis" are "Cystic Fibrosis" (13 trials), "Breast Cancer" (11 trials), "Atrial Fibrillation" (7 trials), "Coronary Artery Disease" (7 trials) and "Acute Myeloid Leukemia" (4 trials). Many other conditions were trialed in "HAGA Ziekenhuis" in a lesser frequency.

Clinical Trials Intervention Types at HAGA Ziekenhuis


Most popular intervention types in "HAGA Ziekenhuis" are "Drug" (136 trials), "Device" (27 trials), "Other" (23 trials), "Procedure" (21 trials) and "Radiation" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (24 trials), "IVA" (10 trials), "Docetaxel" (6 trials), "Daratumumab" (5 trials) and "TEZ/IVA" (5 trials). Other intervention names were less common.

Clinical Trials Genders at HAGA Ziekenhuis


The vast majority of trials in "HAGA Ziekenhuis" are 178 trials for "All" genders, 17 trials for "Female" genders and 7 trials for "Male" genders.

Clinical Trials Status at HAGA Ziekenhuis


Currently, there are NaN active trials in "HAGA Ziekenhuis". 3 are not yet recruiting, 35 are recruiting, 34 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 90 completed trials in HAGA Ziekenhuis, undefined suspended trials, and 17 terminated clinical trials to date.
Out of the total trials that were conducted in HAGA Ziekenhuis, 5 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 39 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 83Phase 3: 83Phase 2: 42Phase 2: 42Not Applicable: 39Not Applicable: 39Phase 4: 12Phase 4: 12Phase 1: 5Phase 1: 5

Created with Highcharts 11.1.0Trials StatusCompleted: 90Completed: 90Recruiting: 35Recruiting: 35Active, not recruiting: 34Active, not recruiting: 34Unknown status: 22Unknown status: 22Terminated: 17Terminated: 17Not yet recruiting: 3Not yet recruiting: 3Approved for marketing: 1Approved for marketing: 1

Departments of HAGA Ziekenhuis


HAGA Ziekenhuis has several departments that took part in Clinical trials: "HAGA, location Juliana Children's Hospital" - 4 trials, "Leyenburg Ziekenhuis; Internal Medecine" - 2 trials
Departments List
Total Rows: 2